Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03BMT
|
||||
Former ID |
DIB015799
|
||||
Drug Name |
EphB4 inhibitors
|
||||
Synonyms |
EphB4 inhibitors (cancer); EphB4 inhibitors (cancer), AstraZeneca
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [552080] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1cnc(nc1Nc1c(ccc2c1OCO2)Cl)Nc1cc(cc(c1)N1CCOCC1)N1CCOC<br />C1
|
||||
Target and Pathway | |||||
Target(s) | Ephrin type-B receptor 4 | Target Info | Inhibitor | [543507] | |
KEGG Pathway | Axon guidance | ||||
WikiPathways | Vitamin D Receptor Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.